Skip to main content
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · IEX Real-Time Price · USD
2.830
-0.220 (-7.21%)
At close: Jul 19, 2024, 4:00 PM
2.840
+0.010 (0.35%)
Pre-market: Jul 22, 2024, 6:59 AM EDT

Allogene Therapeutics Revenue

Allogene Therapeutics had revenue of $65.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $22.00K. In the year 2023, Allogene Therapeutics had annual revenue of $95.00K.

Revenue (ttm)
$65.00K
Revenue Growth
-48.00%
P/S Ratio
9,090.13
Revenue / Employee
$279
Employees
233
Market Cap
590.86M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202395.00K-61.00K-39.10%
Dec 31, 2022156.00K-113.93M-99.86%
Dec 31, 2021114.09M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.19B
Varex Imaging 855.80M
Orthofix Medical 760.05M
ZimVie 350.20M
Adaptive Biotechnologies 174.50M
Surmodics 142.96M
Verve Therapeutics 16.05M
Revenue Rankings

ALLO News

More News